Controversies in Cardiology
This book considers several clinical and interventional topics for which there is either uncertainty, continued debate and/or no consensus based on current guidelines. Leading international experts explore each controversy, probing the existing evidence and current opinions. Each chapter outlines th...
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Cham :
Springer International Publishing
2015.
|
| Edición: | 1st ed |
| Colección: | Springer eBooks.
|
| Acceso en línea: | Conectar con la versión electrónica |
| Ver en Universidad de Navarra: | https://innopac.unav.es/record=b32882695*spi |
Tabla de Contenidos:
- Section 1. Special situations of controversial, increased, or unknown cardiovascular risk
- Optimal management of old and new CV risk factors
- Angiographic narrowing prior to ST elevation MI. Are the lesions non-obstructive?
- Preventing future acute coronary events - Identify and treat vulnerable plaques or vulnerable, high risk patients?
- Treatment of diabetes and coronary artery disease
- Elevated triglycerides and atherosclerosis
- Patent foramen ovale and stroke
- Systolic hypertension in the elderly
- Section 2. Cardiovascular diagnosis
- CT angiography vs routine stress testing in patients with chest pain seen in the emergency room to exclude coronary artery disease
- Takotsubo cardiomyopathy- frequency, diagnosis and management
- Chest pain in women {u2013} evaluation and management
- Section 3. Cardiovascular management
- Myocardial infarction and 2normal3 coronary arteries on angiography
- Management of intractable angina when PCI or CABG is not an option
- Invasive management of CAD in patients on anticoagulants
- Managing intracoronary thrombus during PCI
- Optimal management of multivessel disease {u2013} PCI vs CABG vs medical therapy alone
- Appropriate therapy for severe left main disease
- Radial vs femoral procedures for angiography and PCI
- DAPT after stenting in stable and acute coronary syndromes {u2013} does the drug combination really matter?
- CAD management in patients with significant renal dysfunction or on dialysis
- What is the optimal stent design?
- Oral pharmacotherapy in the prevention of restenosis: prednisolone, rapamune, colchicine and cilostazol
- When should ablation be considered in the treatment of atrial fibrillation?
- Use of advanced and expensive cardiac procedures in the very elderly- Can or should we limit access?
- Cost benefits of TAVR- Should the indications be expanded?.
